Altasciences’ CNS Center of Excellence is globally renowned for offering expert, fully integrated early phase drug development services. Whether large or small molecule, our streamlined solutions can help move your compound from prototype formulation through to commercialization, delivering up to 40% in time savings.

Our in-house preclinical, clinical, bioanalytical, and manufacturing teams have completed over 200 neurological studies to date. By partnering with us, you benefit from:

•    a CNS research team comprised of neuroscientists, clinicians, psychiatrists, pharmacists, and other interdisciplinary experts;
•    a dedicated preclinical facility with expertise in cell and gene therapy;
•    three state-of-the-art clinical research sites;
•    10 on-site driving simulators for cognitive testing; and
•    300+ scientists for bioanalytical support.

And there’s more! Discover our full range of CNS drug development services here.

 Questions? Contact one of our experts.

Related resources that may interest you:

Scientific Journal: Integrated CNS Drug Development Solutions Lessen Complexities
Webinar: Practical Approaches When Conducting Clinical Trials With Psychedelics
Educational Video: Development Strategies for Neurological Drugs

Listen to the Latest Audiobook Releases of The Altascientist

Delve deeper into the critical processes behind early phase drug development with audio versions of The Altascientist, written by our experts with you in mind:

Issue 34 — Toxicokinetics, Pharmacokinetics, and Pharmacodynamics
Take a closer look at the collection and use of a novel drug's PK/PD data in early phase drug development, and why this data is critical to setting up your clinical trials.
Listen to the audiobook >>>

Issue 35 — Critical Considerations for the Compliant Manufacture of Highly Potent Drugs
Learn how facilities, equipment, and processes for HPAPIs should be adapted to maximize safety and success for your development projects.
Listen to the audiobook >>>​​​

Issue 36 — Nonclinical Studies in Cell and Gene Therapy
Discover expert approaches to mitigating complex challenges, improving study efficiency, and maximizing translational opportunities to first-in-human trials.
Listen to the audiobook >>>

Issue 37 — Quantitative PCR (qPCR) and Droplet Digital (ddPC)
Foster a more comprehensive understanding of PCR and discover a more sophisticated approach to data analysis and experimentation.
Listen to the audiobook >>>

SPEAK WITH AN EXPERT

VISIT THE FULL LIBRARY

Angel Reyes Joins Altasciences as General Manager of CDMO Services

Altasciences is pleased to welcome Angel Reyes as General Manager, Contract Development and Manufacturing Organization (CDMO) Services. Having previously been the Director of Operations at Catalent, he brings to Altasciences over a decade of experience in management and supervisory roles.

CONTINUE READING

Altasciences Completes Expansion of New State-Of-The-Art Laboratory in Columbia, Missouri

The impressive 8,000-square-foot space, which includes a test material department, features state-of-the-art equipment and forty-eight workbenches, with a vast range of services, including ligand binding assays, flow cytometry, biomarker analysis, and cell culture capabilities.

CONTINUE READING

IN OTHER NEWS…

Altasciences’ Marie-Hélène Raigneau and Steve Mason Named Most Influential COOs in the Healthcare Industry to Follow in 2023

In honor of this recognition, Insights Care published two in-depth interviews with Altasciences’ Co-chief Operating Officers, providing a glimpse into their daily roles, their journeys to becoming part of Altasciences, and their thoughts on the industry.

•   Read Marie-Hélène’s interview

•   Read Steve Mason’s interview

View more Altasciences news on our website.